The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 23, 2016

Filed:

May. 03, 2013
Applicants:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Lycera Corporation, Ann Arbor, MI (US);

Inventors:

Thomas D. Aicher, Ann Arbor, MI (US);

Kenneth Jay Barr, Boston, MA (US);

Vladimir Simov, South Boston, MA (US);

William D. Thomas, San Jose, CA (US);

Peter L. Toogood, Ann Arbor, MI (US);

Chad A. Van Huis, Hartland, MI (US);

Assignees:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Lycera Corporation, Ann Arbor, MI (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 233/72 (2006.01); C07D 263/22 (2006.01); C07D 207/12 (2006.01); C07C 317/40 (2006.01); A61K 31/10 (2006.01); A61K 31/16 (2006.01); A61K 31/47 (2006.01); C07C 311/30 (2006.01); C07D 263/44 (2006.01); C07D 207/27 (2006.01); C07D 209/52 (2006.01); C07D 211/96 (2006.01); C07D 213/82 (2006.01); C07D 215/38 (2006.01); C07D 217/22 (2006.01); C07D 223/16 (2006.01); C07D 231/18 (2006.01); C07D 401/12 (2006.01); C07D 471/04 (2006.01); C07D 491/052 (2006.01);
U.S. Cl.
CPC ...
C07C 317/40 (2013.01); C07C 311/30 (2013.01); C07D 207/12 (2013.01); C07D 207/27 (2013.01); C07D 209/52 (2013.01); C07D 211/96 (2013.01); C07D 213/82 (2013.01); C07D 215/38 (2013.01); C07D 217/22 (2013.01); C07D 223/16 (2013.01); C07D 231/18 (2013.01); C07D 233/72 (2013.01); C07D 263/22 (2013.01); C07D 263/44 (2013.01); C07D 401/12 (2013.01); C07D 471/04 (2013.01); C07D 491/052 (2013.01); C07C 2101/02 (2013.01); C07C 2101/14 (2013.01); C07C 2102/00 (2013.01); C07C 2102/10 (2013.01); C07C 2102/22 (2013.01); C07C 2102/42 (2013.01);
Abstract

The invention provides bicyclic sulfone compounds, pharmaceutical compositions, methods of inhibiting RORy activity, reducing the amount of iL-17 in a subject, and treating immune disorders and inflammatory disorders using such bicyclic sulfone compounds. Another aspect of the invention provides a method of treating a subject suffering from a medical disorder. The method comprises administering to the subject a therapeutically effective amount of one or more bicyclic sulfone compounds described herein. In certain other embodiments, the disorder is rheumatoid arthritis.


Find Patent Forward Citations

Loading…